The FY2025 (Dec) proxy of Structure Therapeutics names 17 peer companies for pay. Among Structure Therapeutics and these peers, CEO pay was 6th highest of 8 and total shareholder return was 2nd highest of 8.
6th highest of 8in Structure Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:
$2.5M$19.2M
2nd highest of 8in Structure Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:
$20$524
Pay peer group, FY2025 (Dec) proxy
| Madrigal Pharmaceuticals | ||
| Revolution Medicines | ||
| Disc Medicine | ||
| Arcus Biosciences | ||
| IDEAYA Biosciences | ||
| Denali Therapeutics | ||
| Keros Therapeutics | ||
| 89bio, Inc. | Not disclosed | Not disclosed |
| Akero Therapeutics, Inc. | Not disclosed | Not disclosed |
| Arrowhead Pharmaceuticals | Not disclosed | Not disclosed |
| Biohaven | Not disclosed | Not disclosed |
| Crinetics Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Dianthus Therapeutics, Inc. | Not disclosed | Not disclosed |
| Longboard Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Morphic Holding, Inc. | Not disclosed | Not disclosed |
| Pliant Therapeutics, Inc. | Not disclosed | Not disclosed |
| Vaxcyte | Not disclosed | Not disclosed |
17 companies
Changes by year
FY2025 (Dec) proxy
- AddedDianthus Therapeutics, Inc.pay peer groupBased on the peer group analysis performed by Aon in 2024, RAPT Therapeutics, Inc. and Ventyx Biosciences, Inc. were removed from the peer group as they no longer fit the selection criteria, while Dianthus Therapeutics, Inc. and Disc Medicine, Inc. were added as companies with characteristics that were more similar to the Company
- AddedDisc Medicinepay peer groupBased on the peer group analysis performed by Aon in 2024, RAPT Therapeutics, Inc. and Ventyx Biosciences, Inc. were removed from the peer group as they no longer fit the selection criteria, while Dianthus Therapeutics, Inc. and Disc Medicine, Inc. were added as companies with characteristics that were more similar to the Company
- RemovedCerevel Therapeutics Holdings, Inc.pay peer groupTwo companies that had been included in the 2024 peer group — Cerevel Therapeutics Holdings, Inc. and Karuna Therapeutics — were excluded from the 2025 peer group as each was acquired and ceased to be publicly traded
- RemovedKaruna Therapeuticspay peer groupTwo companies that had been included in the 2024 peer group — Cerevel Therapeutics Holdings, Inc. and Karuna Therapeutics — were excluded from the 2025 peer group as each was acquired and ceased to be publicly traded
- RemovedRAPT Therapeutics, Inc.pay peer groupBased on the peer group analysis performed by Aon in 2024, RAPT Therapeutics, Inc. and Ventyx Biosciences, Inc. were removed from the peer group as they no longer fit the selection criteria, while Dianthus Therapeutics, Inc. and Disc Medicine, Inc. were added as companies with characteristics that were more similar to the Company
- RemovedVentyx Biosciences, Inc.pay peer groupBased on the peer group analysis performed by Aon in 2024, RAPT Therapeutics, Inc. and Ventyx Biosciences, Inc. were removed from the peer group as they no longer fit the selection criteria, while Dianthus Therapeutics, Inc. and Disc Medicine, Inc. were added as companies with characteristics that were more similar to the Company
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.